Loading stock data…
$3.72-0.09 (-2.36%)
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products and specimen collection devices in the United States, Europe, Africa, and internationally.
OraSure Technologies, Inc. in the Healthcare sector is trading at $3.75 with a market capitalization of $240M. Wall Street consensus targets $4.00 (1 analysts), implying a +6.8% move over the next 12 months. The stock is currently 18% below its 52-week high of $4.58, remaining 9.2% above its 200-day moving average. On fundamentals, Piotroski 2/9 flags weak fundamentals. The Whystock Score of 55/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $30.64M↑ | $27.93M↑ | $26.76M↓ | $27.09M↓ | $31.24M |
| Gross Profit | $13.32M↑ | $11.80M↑ | $10.97M↓ | $11.77M↓ | $13.16M |
| Operating Income | -$17.15M↑ | -$23.18M↓ | -$16.85M↓ | -$15.71M↑ | -$17.29M |
| Net Income | $6.25M↑ | -$22.38M↓ | -$19.29M↓ | -$13.71M↑ | -$19.69M |
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products and specimen collection devices in the United States, Europe, Africa, and internationally. It offers OraQuick Rapi...